Insider Trading activities of Intermune Inc insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Intermune Inc since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Intermune Inc since year 2005. Table 2 shows the detailed insider transactions of Intermune Inc since 2005. The reporting company's ticker symbol is ITMN. The reporting company's CIK number is 1087432.
The total value of stock buying since 2005 is $61,894,993.
The total value of stock sales since 2005 is $144,655,430.
The total value of stock option exercises since 2005 is $61,875,572.


Go to page:  1   2 
Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Intermune Inc (ITMN).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2014-09 0 $0 7,500 $551,032 13,500 $172,440
2014-08 0 $0 210,249 $9,634,672 250,837 $2,789,810
2014-07 0 $0 37,382 $1,605,357 35,000 $432,250
2014-06 0 $0 64,849 $2,786,833 57,085 $727,719
2014-05 0 $0 152,488 $5,710,675 160,282 $1,690,727
2014-04 0 $0 3,673 $123,287 0 $0
2014-03 0 $0 117,395 $3,638,131 0 $0
2014-02 0 $0 220,572 $7,294,369 174,942 $3,048,227
2014-01 0 $0 100,000 $1,751,149 0 $0
2013-12 0 $0 20,000 $279,800 0 $0
2013-10 0 $0 70,000 $1,080,030 50,000 $436,500
2013-08 6,600 $95,874 0 $0 0 $0
2012-09 0 $0 0 $0 33,334 $291,005
2011-10 0 $0 0 $0 27,082 $301,828
2011-07 0 $0 36,880 $1,327,032 36,880 $321,960
2011-06 0 $0 211,859 $7,153,302 155,975 $2,029,958
2011-05 0 $0 979,303 $38,276,472 909,876 $15,666,920
2011-04 0 $0 80,519 $3,832,826 80,519 $2,571,902
2011-03 0 $0 204,183 $9,093,098 142,743 $4,895,319
2011-02 0 $0 20,387 $732,702 20,387 $297,999
2011-01 0 $0 0 $0 52,002 $724,751
2010-12 0 $0 507,663 $14,797,361 500,141 $7,814,703
2010-11 8,308 $110,247 0 $0 0 $0
2010-05 0 $0 44,886 $469,693 0 $0
2010-03 0 $0 367,521 $14,281,516 329,615 $3,711,939
2010-01 4,255,320 $60,000,012 0 $0 45,000 $202,500
2009-05 0 $0 13,597 $159,973 0 $0
2008-09 0 $0 6,023 $109,110 0 $0
2008-08 1,000 $17,450 0 $0 0 $0
2008-07 0 $0 30,000 $505,530 30,000 $358,500
2008-05 0 $0 24,539 $375,841 18,539 $187,429
2008-01 0 $0 36,482 $637,778 0 $0
2007-12 0 $0 9,375 $126,093 89,161 $1,150,190
2007-11 1,000 $16,810 5,625 $99,618 0 $0
2007-10 0 $0 41,860 $813,192 119,298 $1,515,243
2007-07 0 $0 90,272 $2,445,161 90,272 $1,157,970
2006-12 0 $0 90,897 $2,119,847 90,897 $1,460,794
2006-11 0 $0 71,134 $1,533,644 43,953 $664,016
2006-10 0 $0 147,050 $3,228,664 147,050 $2,189,853
2006-09 0 $0 35,000 $603,930 35,000 $376,600
2006-08 0 $0 43,718 $699,592 14,713 $158,311
2006-03 0 $0 47,441 $920,314 39,610 $697,802
2006-02 0 $0 311,942 $5,857,806 258,822 $3,830,407
2005-05 5,000 $55,664 0 $0 0 $0
2005-03 141,800 $1,598,936 0 $0 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Intermune Inc insiders (ITMN)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2014-09-03 Kabakoff David S (Director) Option Ex 6,000 9.99 59,940
2014-09-02 Powell Andrew Kenneth William (EVP, GC & Secretary) Sale 7,500 73.47 551,032
2014-09-02 Powell Andrew Kenneth William (EVP, GC & Secretary) Option Ex 7,500 15.00 112,500
2014-08-21 Di Nepi Giacomo (EVP Managing Director, Europe) Option Ex 45,312 18.28 828,212
2014-08-15 Di Nepi Giacomo (EVP Managing Director, Europe) Sale 10,000 51.28 512,750
2014-08-15 Di Nepi Giacomo (EVP Managing Director, Europe) Option Ex 10,000 13.56 135,600
2014-08-13 Nolan Sean P. (EVP & CBO) Sale 17,000 50.00 850,000
2014-08-13 Nolan Sean P. (EVP & CBO) Option Ex 17,000 9.29 157,930
2014-08-13 Arata Paul D (EVP, Human Resources & Admin) Sale 7,500 50.00 375,000
2014-08-13 Arata Paul D (EVP, Human Resources & Admin) Option Ex 7,500 9.99 74,925
2014-08-11 Hodgman John (EVP, Finance & CFO) Sale 4,724 43.05 203,358
2014-08-07 Welch Daniel G (Chairman, CEO and President) Sale 24,900 45.17 1,124,807
2014-08-07 Welch Daniel G (Chairman, CEO and President) Option Ex 24,900 8.73 217,377
2014-08-05 Welch Daniel G (Chairman, CEO and President) Sale 146,125 44.95 6,568,757
2014-08-05 Welch Daniel G (Chairman, CEO and President) Option Ex 146,125 9.42 1,375,766
2014-07-17 Arata Paul D (EVP, Human Resources & Admin) Sale 2,382 41.00 97,662
2014-07-15 Leff Jonathan A (EVP, Research & Development) Sale 35,000 43.08 1,507,695
2014-07-15 Leff Jonathan A (EVP, Research & Development) Option Ex 35,000 12.35 432,250
2014-06-18 Nolan Sean P. (EVP & CBO) Sale 10,000 47.10 471,000
2014-06-18 Nolan Sean P. (EVP & CBO) Option Ex 10,000 9.29 92,899
2014-06-16 Welch Daniel G (Chairman, CEO and President) Sale 15,000 45.02 675,255
2014-06-16 Welch Daniel G (Chairman, CEO and President) Option Ex 15,000 19.01 285,150
2014-06-13 Nolan Sean P. (EVP & CBO) Sale 10,000 44.35 443,500
2014-06-13 Nolan Sean P. (EVP & CBO) Option Ex 10,000 9.29 92,899
2014-06-06 Nolan Sean P. (EVP & CBO) Sale 10,000 41.25 412,500
2014-06-06 Nolan Sean P. (EVP & CBO) Option Ex 10,000 9.29 92,899
2014-06-05 Leff Jonathan A (EVP, Research & Development) Sale 190 39.66 7,535
2014-06-05 Hodgman John (EVP, Finance & CFO) Sale 921 39.66 36,527
2014-06-04 Di Nepi Giacomo (EVP Managing Director, Europe) Sale 12,085 39.79 480,898
2014-06-04 Di Nepi Giacomo (EVP Managing Director, Europe) Option Ex 12,085 13.56 163,872
2014-06-04 Welch Daniel G (Chairman, CEO and President) Sale 3,914 39.19 153,401
2014-06-03 Nolan Sean P. (EVP & CBO) Sale 385 38.78 14,930
2014-06-03 Leff Jonathan A (EVP, Research & Development) Sale 1,153 38.78 44,713
2014-06-03 Hodgman John (EVP, Finance & CFO) Sale 1,201 38.78 46,574
2014-05-30 Nolan Sean P. (EVP & CBO) Option Ex 1,000 .00 0
2014-05-30 Verwiel Frank (Director) Option Ex 3,000 .00 0
2014-05-30 Russell Angus C. (Director) Option Ex 3,000 .00 0
2014-05-30 Di Nepi Giacomo (EVP Managing Director, Europe) Option Ex 2,250 .00 0
2014-05-30 Leff Jonathan A (EVP, Research & Development) Option Ex 3,000 .00 0
2014-05-30 Arata Paul D (EVP, Human Resources & Admin) Option Ex 1,500 .00 0
2014-05-30 Ekman Lars (Director) Option Ex 3,000 .00 0
2014-05-30 Powell Andrew Kenneth William (EVP, GC & Secretary) Sale 500 39.32 19,662
2014-05-30 Drapeau Louis (Director) Option Ex 3,000 .00 0
2014-05-30 Healy James (Director) Option Ex 3,000 .00 0
2014-05-30 Bienaime Jean Jacques (Director) Option Ex 3,000 .00 0
2014-05-30 Hodgman John (EVP, Finance & CFO) Option Ex 2,250 .00 0
2014-05-30 Welch Daniel G (Chairman, CEO and President) Sale 4,565 40.06 182,892
2014-05-30 Welch Daniel G (Chairman, CEO and President) Option Ex 8,750 .00 0
2014-05-29 Powell Andrew Kenneth William (EVP, GC & Secretary) Sale 500 39.56 19,780
2014-05-29 Kabakoff David S (Director) Sale 5,000 39.56 197,800
2014-05-27 Welch Daniel G (Chairman, CEO and President) Sale 6,949 40.14 278,967
2014-05-27 Welch Daniel G (Chairman, CEO and President) Option Ex 6,949 15.37 106,806
2014-05-23 Arata Paul D (EVP, Human Resources & Admin) Sale 10,000 40.00 400,000
2014-05-23 Arata Paul D (EVP, Human Resources & Admin) Option Ex 10,000 8.05 80,500
2014-05-23 Welch Daniel G (Chairman, CEO and President) Sale 34,544 40.01 1,381,967
2014-05-23 Welch Daniel G (Chairman, CEO and President) Option Ex 34,544 12.04 415,737
2014-05-19 Nolan Sean P. (EVP & CBO) Sale 7,500 39.50 296,250
2014-05-19 Welch Daniel G (Charman, CEO and President) Sale 11,607 38.00 441,066
2014-05-19 Welch Daniel G (Charman, CEO and President) Option Ex 11,607 15.34 178,051
2014-05-14 Hodgman John (EVP, Finance & CFO) Sale 941 35.19 33,112
2014-05-12 Leff Jonathan A (EVP, Research & Development) Sale 3,131 36.14 113,154
2014-05-12 Welch Daniel G (Charman, CEO and President) Sale 4,175 36.14 150,871
2014-05-08 Nolan Sean P. (Executive VP & CBO) Sale 2,644 35.85 94,779
2014-05-06 Welch Daniel G (Chairman, CEO and President) Sale 31,519 36.01 1,134,999
2014-05-06 Welch Daniel G (Chairman, CEO and President) Option Ex 31,519 13.14 414,065
2014-05-05 Welch Daniel G (Chairman, CEO and President) Sale 28,913 33.39 965,376
2014-05-05 Welch Daniel G (Chairman, CEO and President) Option Ex 28,913 17.14 495,568
2014-04-01 Welch Daniel G (Chairman, CEO and President) Sale 3,673 33.57 123,287
2014-03-06 Leff Jonathan A (EVP of R&D) Sale 748 31.75 23,749
2014-03-06 Hodgman John (EVP-Finance & CFO) Sale 3,631 31.75 115,284
2014-03-04 Di Nepi Giacomo (EVP, Managing Director, Europe) Sale 70,000 30.84 2,158,730
2014-03-04 Leff Jonathan A (EVP of R&D) Sale 20,000 31.51 630,280
2014-03-03 Leff Jonathan A (EVP of R&D) Sale 7,361 29.43 216,612
2014-03-03 Welch Daniel G (Chairman, CEO and President) Sale 15,655 31.52 493,476
2014-02-25 Hodgman John (EVP-Finance & CFO) Sale 159,485 35.69 5,692,019
2014-02-25 Hodgman John (EVP-Finance & CFO) Option Ex 133,855 14.93 1,998,455
2014-02-25 Welch Daniel G (Chairman, CEO and President) Sale 41,087 32.63 1,340,750
2014-02-25 Welch Daniel G (Chairman, CEO and President) Option Ex 41,087 25.55 1,049,772
2014-02-03 Welch Daniel G (Chairman, CEO and President) Sale 20,000 13.08 261,600
2014-01-16 Welch Daniel G (Chairman, CEO and President) Sale 50,000 18.02 901,099
2014-01-10 Welch Daniel G (Chairman, CEO and President) Sale 50,000 17.00 850,050
2013-12-02 Welch Daniel G (Chairman, CEO and President) Sale 20,000 13.99 279,800
2013-10-01 Welch Daniel G (Chairman, CEO and President) Sale 70,000 15.43 1,080,030
2013-10-01 Welch Daniel G (Chairman, CEO and President) Option Ex 50,000 8.73 436,500
2013-08-27 Russell Angus C. (Director) Buy 4,950 14.37 71,131
2013-08-26 Russell Angus C. (Director) Buy 1,650 15.00 24,743
2012-09-14 Di Nepi Giacomo (SVP, Managing Director, Europe) Option Ex 33,334 8.73 291,005
2011-10-07 Di Nepi Giacomo (SVP, Managing Director, Europe) Option Ex 27,082 11.14 301,828
2011-07-27 Bradford Williamson Z Iii (SVP-Clinical Science) Sale 1,800 35.16 63,286
2011-07-27 Bradford Williamson Z Iii (SVP-Clinical Science) Option Ex 1,800 8.73 15,714
2011-07-20 Porter Steven Bryant (Chief Medical Officer) Sale 7,290 36.25 264,240
2011-07-20 Porter Steven Bryant (Chief Medical Officer) Option Ex 7,290 8.73 63,641
2011-07-20 Armstrong Marianne (SVP Ch Reg & Drug Safety Officer) Sale 7,250 36.23 262,696
2011-07-20 Armstrong Marianne (SVP Ch Reg & Drug Safety Officer) Option Ex 7,250 8.73 63,292
2011-07-13 Bradford Williamson Z Iii (SVP-Clinical Science) Sale 6,000 35.98 215,850
2011-07-13 Bradford Williamson Z Iii (SVP-Clinical Science) Option Ex 6,000 8.73 52,380
2011-07-06 Porter Steven Bryant (Chief Medical Officer) Sale 7,290 35.82 261,120
2011-07-06 Porter Steven Bryant (Chief Medical Officer) Option Ex 7,290 8.73 63,641
2011-07-06 Armstrong Marianne (SVP Ch Reg & Drug Safety Officer) Sale 7,250 35.84 259,840
2011-07-06 Armstrong Marianne (SVP Ch Reg & Drug Safety Officer) Option Ex 7,250 8.73 63,292
2011-06-29 Bradford Williamson Z Iii (SVP-Clinical Science) Sale 6,000 35.47 212,838
2011-06-29 Bradford Williamson Z Iii (SVP-Clinical Science) Option Ex 6,000 12.74 76,440
2011-06-22 Porter Steven Bryant (Chief Medical Officer) Sale 7,290 32.02 233,462
2011-06-22 Porter Steven Bryant (Chief Medical Officer) Option Ex 7,290 8.73 63,641
2011-06-22 Armstrong Marianne (SVP Ch Reg & Drug Safety Officer) Sale 7,250 35.02 253,909
2011-06-22 Armstrong Marianne (SVP Ch Reg & Drug Safety Officer) Option Ex 7,250 8.73 63,292
2011-06-21 Bradford Williamson Z Iii (SVP-Clinical Science) Sale 6,000 35.00 210,000
2011-06-21 Bradford Williamson Z Iii (SVP-Clinical Science) Option Ex 6,000 12.74 76,440
2011-06-21 Porter Steven Bryant (Chief Medical Officer) Sale 7,290 35.00 255,150
2011-06-21 Porter Steven Bryant (Chief Medical Officer) Option Ex 7,290 8.73 63,641
2011-06-21 Armstrong Marianne (SVP Ch Reg & Drug Safety Officer) Sale 7,250 35.00 253,750
2011-06-21 Armstrong Marianne (SVP Ch Reg & Drug Safety Officer) Option Ex 7,250 8.73 63,292
2011-06-20 Seiwert Scott (SVP, Rsearch & Technical Dev.) Sale 30,188 33.18 1,001,788
2011-06-20 Seiwert Scott (SVP, Rsearch & Technical Dev.) Option Ex 23,891 12.28 293,381
2011-06-20 Porter Steven Bryant (Chief Medical Officer) Sale 7,321 34.00 248,914
2011-06-20 Armstrong Marianne (SVP Ch Reg & Drug Safety Officer) Sale 7,321 34.00 248,914
2011-06-17 Steele Robin Joan (SVP, GC, Secretary) Sale 38,721 33.78 1,307,995
2011-06-17 Steele Robin Joan (SVP, GC, Secretary) Option Ex 30,132 15.60 469,998
2011-06-14 Cohen Alan Howard (SVP, Medical Affairs) Sale 20,849 33.00 688,017
2011-06-14 Cohen Alan Howard (SVP, Medical Affairs) Option Ex 16,666 8.73 145,494
2011-06-14 Simon Howard Allan (SVP-Human Resources) Sale 21,213 33.00 700,029
2011-06-14 Simon Howard Allan (SVP-Human Resources) Option Ex 17,030 12.04 204,956
2011-06-08 Simon Howard Allan (SVP-Human Resources) Sale 30,754 32.82 1,009,315
2011-06-08 Simon Howard Allan (SVP-Human Resources) Option Ex 21,176 20.44 432,943
2011-06-02 Kabakoff David S (Director) Sale 2,000 36.41 72,820
2011-06-01 Bradford Williamson Z Iii (SVP-Clinical Science) Sale 6,000 36.79 220,722
2011-06-01 Bradford Williamson Z Iii (SVP-Clinical Science) Option Ex 6,000 12.74 76,440
2011-06-01 Porter Steven Bryant (Chief Medical Officer) Sale 3,226 37.00 119,378
2011-06-01 Armstrong Marianne (SVP Ch Reg & Drug Safety Officer) Sale 3,186 36.50 116,301
2011-05-31 Cohen Alan Howard (SVP, Medical Affairs) Sale 36,189 37.16 1,344,747
2011-05-31 Cohen Alan Howard (SVP, Medical Affairs) Option Ex 33,749 11.81 398,575
2011-05-18 Bradford Williamson Z Iii (SVP-Clinical Science) Sale 6,000 37.17 223,020
2011-05-18 Bradford Williamson Z Iii (SVP-Clinical Science) Option Ex 6,000 12.74 76,440
2011-05-18 Simon Howard Allan (SVP-Human Resources) Sale 109,656 38.78 4,252,569
2011-05-18 Simon Howard Allan (SVP-Human Resources) Option Ex 106,223 17.09 1,815,032
2011-05-18 Porter Steven Bryant (Chief Medical Officer) Sale 1,811 37.05 67,093
2011-05-18 Porter Steven Bryant (Chief Medical Officer) Option Ex 1,811 15.34 27,780
2011-05-18 Armstrong Marianne (SVP Ch Reg & Drug Safety Officer) Sale 1,822 37.22 67,822
2011-05-18 Armstrong Marianne (SVP Ch Reg & Drug Safety Officer) Option Ex 1,822 15.34 27,949
2011-05-18 Welch Daniel G (Chairman, CEO and President) Sale 20,750 37.22 772,315
2011-05-17 Di Nepi Giacomo (SVP, Managing Director, Europe) Sale 39,939 37.75 1,507,817
2011-05-17 Di Nepi Giacomo (SVP, Managing Director, Europe) Option Ex 37,499 13.56 508,486
2011-05-16 Bradford Williamson Z Iii (SVP-Clinical Science) Sale 1,562 37.94 59,199
2011-05-16 Bradford Williamson Z Iii (SVP-Clinical Science) Option Ex 604 20.44 12,348
2011-05-16 Welch Daniel G (Chairman, CEO and President) Sale 3,505 38.22 133,961
2011-05-13 Bradford Williamson Z Iii (SVP-Clinical Science) Sale 1,918 39.85 76,424
2011-05-12 Seiwert Scott (SVP, Rsearch & Technical Dev.) Sale 71,443 39.12 2,795,207
2011-05-12 Seiwert Scott (SVP, Rsearch & Technical Dev.) Option Ex 55,148 16.35 901,780
2011-05-12 Bradford Williamson Z Iii (SVP-Clinical Science) Sale 115,842 38.84 4,499,071
2011-05-12 Bradford Williamson Z Iii (SVP-Clinical Science) Option Ex 122,530 17.54 2,362,927
Go to page:  1   2 

Insider trading activities including stock purchases, stock sales, and option exercises of ITMN listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Intermune Inc (symbol ITMN, CIK number 1087432) see the Securities and Exchange Commission (SEC) website.